Hints and tips:
...Mentioned in this podcast: Buffett sounds wildfire alarm as utilities industry enters new era Bayer slashes dividend by 95% as it steps up effort to cut debt Bayer’s struggling Roundup court strategy...
...Bayer: Shares in the German chemicals and pharma company gained 2 per cent after reports it may spin off its CropScience unit....
...In Bayer’s case, its CropScience division, which provides seeds and weedkillers to farmers, feared in 2016 that it could be marginalised as a massive consolidation wave swept through the sector....
...It is also waging campaigns against Glencore, BP and Bayer. BlackRock’s market capitalisation is $118bn....
...Costs from healthcare litigation can spiral as any investors in Bayer can vouch for....
...China founder Neil Shen took Singapore residency (FT) Vodafone in talks to sell Italian business to Swisscom (FT) Uber’s Dara Khosrowshahi defends buyback policy (FT) Shein’s London IPO flirtation (FT) Bayer...
...The German champions beat Union Berlin 1-0 to close the gap on table toppers Bayer Leverkusen to four points. But none of that, frankly matters....
...AstraZeneca said in February it had chosen to open a $360mn factory in Ireland, rather than in the UK, because of a “discouraging tax rate”, while German drugmaker Bayer said last year that it had cut staff...
...News round-up UAE planned to use COP28 summit for oil deals, documents show (FT) Abu Dhabi’s media record under scrutiny after Telegraph deal offer (FT) Bayer chief blames thin drug pipeline on ‘years...
...Bayer maintains the product is safe and says scientific research supports that view....
...Gabriel Harnier group general counsel, BAYER Three years ago, under Harnier’s leadership, the legal team at Bayer, the German pharmaceuticals and life sciences company, moved its contracting, data privacy...
...AbbVie and Eli Lilly have withdrawn from the deal after the German conglomerate Bayer’s pharmaceutical chief executive told the Financial Times on Monday that it was reducing its UK footprint and cutting...
...development Hogan Lovells Innovation in people management PwC Tax & Legal Spain Innovation in diversity and inclusion DWF Innovation strategy DWF In-house Most Innovative In-house Legal Team in Europe Bayer...
...Job moves Former Roche boss Bill Anderson will become the next chief executive of Bayer. His predecessor Werner Baumann has faced pressure from activist investors including Jeff Ubben....
...But it has been bulking up through a series of acquisitions, most recently buying Bayer’s animal-health unit in 2019. The stock is up 15 per cent this year....
...Two weeks after the events organiser met von Götz and Bayer at her home, the editor contacted the woman’s mother....
...“[Investors] have been fairly traumatised by the Bayer Monsanto situation and the Johnson & Johnson talc litigation,” said Bernstein analyst Lisa Clive, referring to two recent multibillion-dollar payouts...
...Mr Manhas is supported by a board that includes Dominic Barton, the former global head of consultants McKinsey and Adrian Percy, the ex-head of R&D at Bayer’s crop science division....
...Elsewhere, Bayer’s shares have dropped by more than one-third over the past year, as it faces legal claims from cancer patients relating to weedkillers it bought as part of its acquisition of US firm Monsanto...
...Bayer, the German pharmaceutical group, also said it would donate 3m of its malaria tablets, but as they are not approved in the US, they need an emergency authorisation from the FDA....
...(FT) News round-up UK accused of letting private equity ‘cash in’ on loans (FT) Bayer spends up to $4bn in gene therapy push (FT + Lex) Dunkin’ closes in on $9bn sale to Inspire Brands (FT + Lex) Fiat...
...One thing to start: Bayer will pay up to $10.9bn to settle a wave of lawsuits over the potential carcinogenic effects of its pesticide product Roundup, relating to its takeover of US agrichemical company...
...Legal claims in the US had wiped tens of billions of dollars from Bayer’s value in the run-up to the meeting. Additional reporting by Chris Flood...
...To some extent, Bayer shareholders have only themselves to blame....
...Roughly one-third of the 30 companies in the Dax index are suffering from some kind of snafu, ranging from Deutsche Bank’s excessive ambitions to Bayer’s disastrous acquisition of Monsanto, which gave it...
International Edition